Application 050698
- Type
- NDA
- Sponsor
- ABBVIE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 125MG/5ML | Yes | No |
| 002 | BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 250MG/5ML | Yes | No |
| 003 | BIAXIN | CLARITHROMYCIN | FOR SUSPENSION;ORAL | 187MG/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050698-001 | BIAXIN | CLARITHROMYCIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | |
| N050698-002 | BIAXIN | CLARITHROMYCIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | |
| N050698-003 | BIAXIN | CLARITHROMYCIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050698-002 | BIAXIN | 250MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N050698-003 | BIAXIN | 187MG/5ML | FOR SUSPENSION / ORAL | 1998-09-30 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | N050698-001 | BIAXIN | 125MG/5ML | FOR SUSPENSION / ORAL | RLD | 1993-12-23 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clarithromycin | CLARITHROMYCIN | Sportpharm LLC | d836ae7e-fdbf-4dcb-a90d-ede1dcbc3e67 | 2026-06-24 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | REMEDYREPACK INC. | 9d5848f0-e9f0-4112-a7ca-bcc8ea2e69c6 | 2026-06-24 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Sportpharm LLC | de33ba3a-9df1-4076-8d5f-b603d2698096 | 2026-04-17 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Solaris Pharma Corporation | 4d42821d-ce7a-7d64-e063-6294a90a0875 | 2026-04-09 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Proficient Rx LP | 88c7ded8-333c-408d-b693-a72881710f59 | 2026-04-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Preferred Pharmaceuticals Inc. | 81c0c69e-b1ae-42f3-9e85-09b8daa75d8d | 2026-03-30 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Major Pharmaceuticals | d0a66646-6774-4fc6-9b26-a98c3a5df274 | 2026-03-26 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | American Health Packaging | 59ebe6cb-c830-45c7-8242-52f9f42a90a0 | 2026-03-19 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Solaris Pharma Corporation | 4d4303f8-88dd-8b88-e063-6394a90ab48f | 2026-03-17 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | American Health Packaging | fa69ea92-0b41-43fb-918f-ed80e0dedf04 | 2026-03-04 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | A-S Medication Solutions | fad1e5a3-59f9-4868-9937-d3b061ab8f00 | 2026-02-19 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | AvPAK | 1920f943-bbf1-cfd9-7475-96a35680a9e0 | 2026-02-11 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Northwind Health Company, LLC | 471f638a-9dd1-09d3-e063-6294a90a2d4f | 2026-01-08 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Northwind Health Company, LLC | f98aacb4-2f01-3e94-e053-6294a90a9aa0 | 2026-01-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
| CLARITHROMYCIN | CLARITHROMYCIN | Chartwell RX, LLC | dea5bd78-7f93-4bc4-a2e4-1b021f5fe098 | 2025-12-10 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Proficient Rx LP | 9eb306e0-ccfb-418c-82ca-204f20a788f7 | 2025-11-01 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | PD-Rx Pharmaceuticals, Inc. | 1d328f5d-73c1-4df7-a3df-71d0e0221181 | 2025-10-17 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | PD-Rx Pharmaceuticals, Inc. | 1cb8a78a-0f07-49e8-a23e-a77628006209 | 2025-10-16 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | PD-Rx Pharmaceuticals, Inc. | 0be243c6-de02-45dd-8210-cab1bbc8dfa7 | 2025-10-15 | Warnings, Adverse reactions | CLARITHROMYCIN |
| Clarithromycin | CLARITHROMYCIN | Direct_Rx | 3ba1da51-ba5b-323f-e063-6294a90a0333 | 2025-09-08 | Warnings, Adverse reactions | CLARITHROMYCIN |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 60048 | SUPPL | 2019-09-19 |
| 60038 | SUPPL | 2019-09-19 |
| 56941 | SUPPL | 2018-12-31 |
| 56893 | SUPPL | 2018-12-20 |
| 56767 | SUPPL | 2018-12-18 |
| 56612 | SUPPL | 2018-11-30 |
| 48704 | SUPPL | 2017-06-12 |
| 48692 | SUPPL | 2017-06-12 |
| 18040 | SUPPL | 2016-06-01 |
| 30299 | SUPPL | 2016-05-31 |
| 18041 | SUPPL | 2015-10-29 |
| 30301 | SUPPL | 2015-10-28 |
| 39134 | SUPPL | 2015-01-12 |
| 8033 | SUPPL | 2015-01-09 |
| 39133 | SUPPL | 2014-08-07 |
| 30300 | SUPPL | 2014-07-28 |
| 30298 | SUPPL | 2013-09-11 |
| 8032 | SUPPL | 2013-09-11 |
| 18039 | SUPPL | 2013-09-09 |
| 18038 | SUPPL | 2013-09-09 |
| 18037 | SUPPL | 2012-07-10 |
| 8030 | SUPPL | 2012-07-10 |
| 30297 | SUPPL | 2012-06-05 |
| 30296 | SUPPL | 2012-05-09 |
| 8031 | SUPPL | 2012-05-09 |
| 39132 | SUPPL | 2012-05-07 |
| 18036 | SUPPL | 2012-05-07 |
| 39131 | SUPPL | 2011-05-31 |
| 39130 | SUPPL | 2011-05-31 |
| 30295 | SUPPL | 2011-05-31 |
| 8029 | SUPPL | 2011-05-31 |
| 8028 | SUPPL | 2009-11-20 |
| 39129 | SUPPL | 2009-09-22 |
| 8027 | SUPPL | 2008-05-29 |
| 30294 | SUPPL | 2008-01-09 |
| 18035 | SUPPL | 2007-12-27 |
| 44204 | ORIG | 2006-09-25 |
| 8026 | SUPPL | 2006-07-13 |
| 8025 | SUPPL | 2005-10-20 |
| 18034 | SUPPL | 2005-10-10 |
| 8024 | SUPPL | 2004-07-21 |
| 8023 | SUPPL | 2002-05-24 |